These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19756408)

  • 21. Interferon regulatory factors in hematopoietic cell differentiation and immune regulation.
    Battistini A
    J Interferon Cytokine Res; 2009 Dec; 29(12):765-80. PubMed ID: 19929577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.
    Agaugué S; Carosella ED; Rouas-Freiss N
    Blood; 2011 Jun; 117(26):7021-31. PubMed ID: 21482709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway.
    Hu G; Barnes BJ
    J Biol Chem; 2009 Jan; 284(5):2767-2777. PubMed ID: 19028697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid regulatory cells in tumor spreading and metastasis.
    Keskinov AA; Shurin MR
    Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular mechanisms in cancer immune escape: a comprehensive review.
    Bhatia A; Kumar Y
    Expert Rev Clin Immunol; 2014 Jan; 10(1):41-62. PubMed ID: 24325346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IRF8 regulates myeloid and B lymphoid lineage diversification.
    Wang H; Morse HC
    Immunol Res; 2009; 43(1-3):109-17. PubMed ID: 18806934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in understanding regulatory myeloid cells.
    Romano A; Vetro C; Adriani M
    Cancer Biol Ther; 2011 Jun; 11(11):923-6. PubMed ID: 21474999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [IRF family transcription factors and host defense signaling].
    Yanai H; Taniguchi T
    Tanpakushitsu Kakusan Koso; 2008 Aug; 53(10):1231-8. PubMed ID: 18681175
    [No Abstract]   [Full Text] [Related]  

  • 29. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.
    Tamura T; Ozato K
    J Interferon Cytokine Res; 2002 Jan; 22(1):145-52. PubMed ID: 11846985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human Cancer.
    Wu WC; Sun HW; Chen J; OuYang HY; Yu XJ; Chen HT; Shuang ZY; Shi M; Wang Z; Zheng L
    Cancer Immunol Res; 2019 Oct; 7(10):1605-1618. PubMed ID: 31387898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional and Epigenetic Regulation of Innate Immune Cell Development by the Transcription Factor, Interferon Regulatory Factor-8.
    Kurotaki D; Tamura T
    J Interferon Cytokine Res; 2016 Jul; 36(7):433-41. PubMed ID: 27379865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MMP3-mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction.
    Banik D; Netherby CS; Bogner PN; Abrams SI
    Oncotarget; 2015 Jun; 6(17):15164-79. PubMed ID: 26008967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of a dominant negative mutation of interferon regulatory factor 5.
    Yang L; Zhao T; Shi X; Nakhaei P; Wang Y; Sun Q; Hiscott J; Lin R
    PLoS One; 2009; 4(5):e5500. PubMed ID: 19430534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
    Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V
    Front Immunol; 2020; 11():1214. PubMed ID: 32793185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
    Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
    J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forced expression of the interferon regulatory factor 2 oncoprotein causes polyploidy and cell death in FDC-P1 myeloid hematopoietic progenitor cells.
    Xie RL; van Wijnen AJ; van der Meijden CM; Stein JL; Stein GS
    Cancer Res; 2002 May; 62(9):2510-5. PubMed ID: 11980642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid-derived suppressor cells: linking inflammation and cancer.
    Ostrand-Rosenberg S; Sinha P
    J Immunol; 2009 Apr; 182(8):4499-506. PubMed ID: 19342621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation.
    Zhou J; Qu Z; Sun F; Han L; Li L; Yan S; Stabile LP; Chen LF; Siegfried JM; Xiao G
    Cancer Immunol Res; 2017 Mar; 5(3):257-268. PubMed ID: 28108629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.
    Peyvandi S; Buart S; Samah B; Vétizou M; Zhang Y; Durrieu L; Polrot M; Chouaib S; Benihoud K; Louache F; Karray S
    Cancer Res; 2015 Oct; 75(20):4292-301. PubMed ID: 26359460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis.
    Park J; Kim K; Lee EJ; Seo YJ; Lim SN; Park K; Rho SB; Lee SH; Lee JH
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17028-33. PubMed ID: 17942705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.